199 related articles for article (PubMed ID: 11805206)
21. Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
Wang SJ; Wang KY; Wang WC; Sihra TS
J Neurosci Res; 2006 Nov; 84(7):1528-42. PubMed ID: 17016851
[TBL] [Abstract][Full Text] [Related]
22. Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine.
Munzar P; Justinova Z; Kutkat SW; Goldberg SR
Eur J Pharmacol; 2002 Feb; 436(1-2):75-82. PubMed ID: 11834249
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.
Gray JA; Roth BL
Brain Res Bull; 2001 Nov; 56(5):441-51. PubMed ID: 11750789
[TBL] [Abstract][Full Text] [Related]
24. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
26. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
[TBL] [Abstract][Full Text] [Related]
27. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
Shinyama H; Masuzaki H; Fang H; Flier JS
Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
[TBL] [Abstract][Full Text] [Related]
28. 5-HT2 receptors, roles and regulation.
Leysen JE; Pauwels PJ
Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
[TBL] [Abstract][Full Text] [Related]
29. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
[TBL] [Abstract][Full Text] [Related]
31. Agonist-induced internalization of leukotriene B(4) receptor 1 requires G-protein-coupled receptor kinase 2 but not arrestins.
Chen Z; Gaudreau R; Le Gouill C; Rola-Pleszczynski M; Stanková J
Mol Pharmacol; 2004 Sep; 66(3):377-86. PubMed ID: 15322228
[TBL] [Abstract][Full Text] [Related]
32. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
34. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
[TBL] [Abstract][Full Text] [Related]
35. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization.
Gray JA; Bhatnagar A; Gurevich VV; Roth BL
Mol Pharmacol; 2003 May; 63(5):961-72. PubMed ID: 12695524
[TBL] [Abstract][Full Text] [Related]
36. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
Holohean AM; Hackman JC
Br J Pharmacol; 2004 Oct; 143(3):351-60. PubMed ID: 15339859
[TBL] [Abstract][Full Text] [Related]
38. Internalization and desensitization of the oxytocin receptor is inhibited by Dynamin and clathrin mutants in human embryonic kidney 293 cells.
Smith MP; Ayad VJ; Mundell SJ; McArdle CA; Kelly E; López Bernal A
Mol Endocrinol; 2006 Feb; 20(2):379-88. PubMed ID: 16179383
[TBL] [Abstract][Full Text] [Related]
39. Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and A(1) adenosine receptor-mediated responses.
Iacovelli L; Franchetti R; Grisolia D; De Blasi A
Mol Pharmacol; 1999 Aug; 56(2):316-24. PubMed ID: 10419550
[TBL] [Abstract][Full Text] [Related]
40. Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization.
Mundell SJ; Luty JS; Willets J; Benovic JL; Kelly E
Br J Pharmacol; 1998 Sep; 125(2):347-56. PubMed ID: 9786508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
